콘텐츠로 건너뛰기
Merck

다음으로 건너뛰기

71663

Sodium phosphate dibasic dodecahydrate

tested according to Ph. Eur.

동의어(들):

Dinatrii phosphas dodecahydricus, sec-Sodium phosphate, Disodium hydrogen phosphate dodecahydrate, Disodium phosphate, di-Sodium hydrogen phosphate dodecahydrate

조직 및 계약 가격을 보려면 로그인를 클릭합니다.

크기 선택

보기 변경
팩 크기SKU재고 정보가격 (VAT 별도)
1 kg

오늘 배송 가능재고 수량 조회Seoul Warehouse South Korea

₩162,603

제품정보 (DICE 배송 시 비용 별도)

Linear Formula:
Na2HPO4 · 12H2O
CAS 번호:
Molecular Weight:
358.14
NACRES:
NA.25
PubChem Substance ID:
UNSPSC Code:
12161700
EC Number:
231-448-7
MDL number:

₩162,603


오늘 배송 가능세부사항


벌크 견적 요청하기
기술 서비스
도움이 필요하신가요? 저희 숙련된 과학자 팀이 도와드리겠습니다.
도움 문의


agency

tested according to Ph. Eur.

Quality Level

assay

98.5-102.5%

form

crystalline

solubility

water: ~35.8 g/L at 20 °C

SMILES string

O.O.O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].OP([O-])([O-])=O

InChI

1S/2Na.H3O4P.12H2O/c;;1-5(2,3)4;;;;;;;;;;;;/h;;(H3,1,2,3,4);12*1H2/q2*+1;;;;;;;;;;;;;/p-2

InChI key

DGLRDKLJZLEJCY-UHFFFAOYSA-L

Application


  • The gelation behavior of thiolated citrus high-methoxyl pectin induced by sodium phosphate dibasic dodecahydrate.: This research explores how sodium phosphate dibasic dodecahydrate influences the gelation properties of thiolated citrus pectin, showcasing potential applications in food science and pharmaceuticals for controlled gelation processes (Chen J et al., 2022).

  • Use of cellulose nanofibril (CNF)/silver nanoparticles (AgNPs) composite in salt hydrate phase change material for efficient thermal energy storage.: Demonstrates the utility of sodium phosphate dibasic dodecahydrate in enhancing the performance of phase change materials, which are critical for energy storage systems, indicating its role in improving thermal energy storage efficiency (Shen Z et al., 2021).


유사한 품목 비교

전체 비교 보기

차이점 표시

1 of 1

이 품목
04273716491.06579
assay

98.5-102.5%

assay

98.5-102.5% (T)

assay

≥99.0% (T)

assay

99.0-102.0% (alkalimetric)

Quality Level

200

Quality Level

200

Quality Level

200

Quality Level

300

form

crystalline

form

crystals

form

crystals

form

solid

solubility

water: ~35.8 g/L at 20 °C

solubility

-

solubility

H2O: 0.1 M at 20 °C, clear, colorless

solubility

218 g/L

agency

tested according to Ph. Eur.

agency

meets analytical specifications of BP, meets analytical specifications of Ph. Eur.

agency

-

agency

reag. ISO, reag. Ph. Eur.


Still not finding the right product?

Explore all of our products under


저장 등급

11 - Combustible Solids

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)



가장 최신 버전 중 하나를 선택하세요:

시험 성적서(COA)

Lot/Batch Number

적합한 버전을 찾을 수 없으신가요?

특정 버전이 필요한 경우 로트 번호나 배치 번호로 특정 인증서를 찾을 수 있습니다.

이 제품을 이미 가지고 계십니까?

문서 라이브러리에서 최근에 구매한 제품에 대한 문서를 찾아보세요.

문서 라이브러리 방문



Karen Sliwa et al.
Heart (British Cardiac Society), 100(24), 1967-1974 (2014-09-18)
Lack of evidence-based data on the spectrum of cardiovascular disease (CVD) in pregnancy or in the postpartum period, as well as on maternal and fetal outcome, provides challenges for treating physicians, particularly in areas of low resources. The objectives of
Yuichiro Yano et al.
Journal of the American College of Cardiology, 65(4), 327-335 (2015-01-31)
Isolated systolic hypertension (ISH), defined as systolic blood pressure (SBP) ≥140 mm Hg and diastolic blood pressure (DBP) <90 mm Hg, in younger and middle-aged adults is increasing in prevalence. The aim of this study was to assess the risk
Matthew R Weir et al.
Journal of clinical hypertension (Greenwich, Conn.), 16(12), 875-882 (2014-10-21)
The effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on blood pressure (BP) and osmotic diuresis- and intravascular volume reduction-related adverse events (AEs) were evaluated using pooled data from four placebo-controlled, phase 3 studies in patients with type 2



국제 무역 품목 번호

SKUGTIN
71663-1KG04061826715154

질문

후기

평점 값 없음

활성 필터